These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2143487)
1. Increase in [3H]PN 200-110 binding to cardiac muscle membrane in streptozocin-induced diabetic rats. Nishio Y; Kashiwagi A; Ogawa T; Asahina T; Ikebuchi M; Kodama M; Shigeta Y Diabetes; 1990 Sep; 39(9):1064-9. PubMed ID: 2143487 [TBL] [Abstract][Full Text] [Related]
2. Increase of voltage-sensitive calcium channels and calcium accumulation in skeletal muscles of streptozocin-induced diabetic rats. Ogawa T; Kashiwagi A; Kikkawa R; Shigeta Y Metabolism; 1995 Nov; 44(11):1455-61. PubMed ID: 7476334 [TBL] [Abstract][Full Text] [Related]
3. Protection by verapamil and nifedipine against ischaemia-induced loss of [3H]-(+)-PN 200-110 binding sites in the rat heart. van Amsterdam FT; van Amsterdam-Magnoni MS; Haas M; Punt NC; Zaagsma J Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):137-42. PubMed ID: 2156175 [TBL] [Abstract][Full Text] [Related]
4. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes. Wei XY; Rutledge A; Triggle DJ Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of specific bindings of nitrendipine and PN200-110 to various crude membranes: induction of irreversible bindings by UV irradiation. Ichida S; Fujisue T; Masada A; Oda Y; Matsuda N; Aonuma S J Biochem; 1989 May; 105(5):760-6. PubMed ID: 2526807 [TBL] [Abstract][Full Text] [Related]
6. Binding of (+)-PN 200-110 to rat pituitaries and to normal and adenomatous human pituitaries. Bression D; Chaumet-Riffaud P; Brandi AM; Comte A; Peillon F; Kiechel JR Mol Cell Endocrinol; 1987 Apr; 50(3):255-61. PubMed ID: 3032711 [TBL] [Abstract][Full Text] [Related]
7. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes. Maan AC; Ptasienski J; Hosey MM J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217 [TBL] [Abstract][Full Text] [Related]
8. Altered [3H]ouabain binding to cardiac muscle in insulin-dependent and non-insulin-dependent diabetic rats. Bányász T; Kovács T Exp Physiol; 1998 Jan; 83(1):65-76. PubMed ID: 9483420 [TBL] [Abstract][Full Text] [Related]
9. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium. Rasmussen RP; Minobe W; Bristow MR Biochem Pharmacol; 1990 Feb; 39(4):691-6. PubMed ID: 2154992 [TBL] [Abstract][Full Text] [Related]
10. Role of L-type Ca2+ channels in attenuated morphine antinociception in streptozotocin-diabetic rats. Gullapalli S; Gurumoorthy K; Kaul CL; Ramarao P Eur J Pharmacol; 2002 Jan; 435(2-3):187-94. PubMed ID: 11821025 [TBL] [Abstract][Full Text] [Related]
11. (+)-[3H]-PN 200-110 binding to cell membranes and intact strips of portal vein smooth muscle: characterization and modulation by membrane potential and divalent cations. Dacquet C; Loirand G; Rakotoarisoa L; Mironneau C; Mironneau J Br J Pharmacol; 1989 May; 97(1):256-62. PubMed ID: 2524235 [TBL] [Abstract][Full Text] [Related]
12. Alterations in Ca(2+)-channels during the development of diabetic cardiomyopathy. Lee SL; Ostadalova I; Kolar F; Dhalla NS Mol Cell Biochem; 1992 Feb; 109(2):173-9. PubMed ID: 1320733 [TBL] [Abstract][Full Text] [Related]
14. Potential-dependent allosteric modulation of 1,4-dihydropyridine binding by d-(cis)-diltiazem and (+/-)-verapamil in living cardiac cells. Porzig H; Becker C Mol Pharmacol; 1988 Aug; 34(2):172-9. PubMed ID: 2457793 [TBL] [Abstract][Full Text] [Related]
15. A novel high affinity class of Ca2+ channel blockers. Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787 [TBL] [Abstract][Full Text] [Related]
16. Effect of propionyl-L-carnitine on L-type calcium channels in human heart sarcolemma. Bevilacqua M; Vago T; Norbiato G Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():31-5. PubMed ID: 1851633 [TBL] [Abstract][Full Text] [Related]
17. The interaction of [3H]PY 108-068 and of [3H]PN 200-110 with calcium channel binding sites in rat brain. Supavilai P; Karobath M J Neural Transm; 1984; 60(3-4):149-67. PubMed ID: 6098633 [TBL] [Abstract][Full Text] [Related]
18. Characterization of dihydropyridine binding sites in the rat brain: hypertension and age-dependent modulation of [3H](+)-PN 200-110 binding. Huguet F; Huchet AM; Gerard P; Narcisse G Brain Res; 1987 May; 412(1):125-30. PubMed ID: 2955850 [TBL] [Abstract][Full Text] [Related]
19. Dihydropyridine binding sites in aerobically perfused, ischemic, and reperfused rat hearts: effect of temperature and time. Gu XH; Dillon JS; Nayler WG J Cardiovasc Pharmacol; 1988 Sep; 12(3):272-8. PubMed ID: 2464098 [TBL] [Abstract][Full Text] [Related]
20. Selective modulation by membrane potential of the interaction of some calcium entry blockers with calcium channels in rat mesenteric artery. Morel N; Godfraind T Br J Pharmacol; 1988 Sep; 95(1):252-8. PubMed ID: 2851351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]